The ACR advocates for policies that support the rheumatology workforce, including ensuring that international physicians and graduates have improved visa access and opportunities to work, research and collaborate in the United States. Although the J-1 visa interview pause has been lifted and J-1 physicians are being prioritized, the uncertainty caused by these policies has posed challenges for both individuals seeking training and the programs that rely on them. These disruptions underscore the need for a reliable visa process for international medical graduates to maintain a robust and diverse rheumatology workforce.
The ACR will continue to actively monitor these developments and inform membership as new details emerge. For further information about the ACR’s regulatory advocacy efforts, email the ACR’s advocacy team at [email protected]. ACR/ARP members can also schedule time to meet with the ACR’s advocacy team.
